Reuters logo
BRIEF-Sierra Oncology Inc - Q4 net loss per share attributable to common stockholders $0.30
March 2, 2017 / 12:18 PM / 7 months ago

BRIEF-Sierra Oncology Inc - Q4 net loss per share attributable to common stockholders $0.30

March 2 (Reuters) - Sierra Oncology Inc

* Sierra Oncology reports 2016 year-end results

* Sierra Oncology Inc -“ existing cash and cash equivalents will be sufficient to fund our current operating plans through approximately mid-2019”

* Sierra Oncology Inc - qtrly net loss per share attributable to common stockholders $0.30 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below